Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,190,000 shares, an increase of 201.5% from the December 31st total of 394,700 shares. Based on an average trading volume of 3,000,000 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Upgrades and Downgrades

AEMD has been the subject of several recent research reports. StockNews.com initiated coverage on shares of Aethlon Medical in a research report on Monday. They issued a “sell” rating for the company. HC Wainwright restated a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Down 1.3 %

AEMD opened at $0.62 on Wednesday. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $1.88. The company has a fifty day moving average of $0.55 and a 200-day moving average of $0.45. The stock has a market cap of $8.70 million, a PE ratio of -0.22 and a beta of 1.61.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.